On the stock market since 2016, it operates in the world of health and science. It has 1,313 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 24% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
The price is looking for direction — no strong breakout, no collapse.
Growth: Sales growth trails the sector average.
Business Quality: Profit power and business quality trail similar companies in the sector.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 82% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $322.7M a year. A small number, but proof the product has real buyers.
There is $336.1M in the vault; even if every debt were paid off, $328.4M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
A loss of $60.5M against $322.7M in annual sales.
Over the last 12 months, executives reported 69 sells against just 20 buys. Not an alarm bell by itself, but a number worth watching.
The stock trades 26% above the average analyst price target.
On our five-subject report card, FLGT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: FLGT is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.